Stockscreener 앱 받기
5.23
0.58%
0.03
전일 마감가:
$5.20
열려 있는:
$5.2
하루 거래량:
875.94K
Relative Volume:
0.48
시가총액:
$502.65M
수익:
-
순이익/손실:
$-144.32M
주가수익비율:
-2.3991
EPS:
-2.18
순현금흐름:
$-105.21M
1주 성능:
+0.48%
1개월 성능:
-19.54%
6개월 성능:
+20.51%
1년 성능:
+17.53%
1일 변동 폭
$5.025
$5.35
1주일 범위
$5.025
$5.65
52주 변동 폭
$2.25
$7.085
Compass Pathways Plc Adr Stock (CMPS) Company Profile
명칭
Compass Pathways Plc Adr
전화
1-716-676-6461
주소
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
CMPS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.235 | 499.29M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
492.01 | 108.68B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
193.81 | 16.41B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.41 | 13.10B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
234.53 | 14.08B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
114.76 | 11.35B | 5.51B | 494.70M | 386.40M | 4.84 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 개시 | Stifel | Buy |
| 2024-07-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-01 | 개시 | Morgan Stanley | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2022-11-21 | 재개 | Berenberg | Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-10-29 | 개시 | Oppenheimer | Outperform |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
| 2021-05-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 개시 | ROTH Capital | Buy |
| 2020-10-14 | 개시 | H.C. Wainwright | Buy |
| 2020-10-13 | 개시 | Berenberg | Buy |
| 2020-10-13 | 개시 | Canaccord Genuity | Buy |
| 2020-10-13 | 개시 | Cowen | Outperform |
| 2020-10-13 | 개시 | Evercore ISI | Outperform |
모두보기
Compass Pathways Plc Adr 주식(CMPS)의 최신 뉴스
Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews
Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews
Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView
COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpTime to Buy? - MarketBeat
This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Compass Pathways soars 62% after December Fair Value signal - Investing.com
Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development (CMPS) - Seeking Alpha
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
Brokerages Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) PT at $16.29 - MarketBeat
Woodline Partners LP Purchases 1,292,927 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 229,806 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Vident Advisory LLC Invests $95,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Driehaus Capital Management LLC Invests $2.01 Million in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Nantahala Capital Management LLC Purchases 1,829,232 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
DAFNA Capital Management LLC Raises Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $16.29 Consensus Target Price from Analysts - Defense World
22NW LP Acquires New Position in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
CMPS Stock Price and Chart — NASDAQ:CMPS - TradingView
HC Wainwright Issues Negative Outlook for CMPS Earnings - Defense World
Analysts Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Price Target at $17.00 - Defense World
Compass (CMPS) Q2 Loss Improves 27% - The Globe and Mail
Can Compass Pathways Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Compass Pathways appoints former GW Pharmaceuticals CEO to board - Investing.com India
Compass Pathways appoints former GW Pharmaceuticals CEO to board By Investing.com - Investing.com South Africa
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip? - Barchart.com
Compass’ stock slips despite psilocybin trial hitting target - Clinical Trials Arena
Compass Pathways reports positive Phase 3 trial results for COMP360 in depression - Investing.com
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - Nasdaq
Compass Pathways Plc Adr (CMPS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
자본화:
|
볼륨(24시간):